Smokers who have tried to quit with a patch, pill, lozenge, inhaler, spray or gum may be interested in a University of Wisconsin-Madison study of a new approach: A vaccine.
A study of NicVAX, an experimental vaccine designed to block nicotine from reaching the brain, is under way at the university’s Center for Tobacco Research and Intervention.
Office of Strategic Communication